Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Hamburg - Delayed Quote • EUR Dentsply Sirona Inc (DY2.HM) Follow Compare 18.11 -0.17 (-0.90%) At close: February 21 at 5:25:13 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Earnings Preview: Dentsply International (XRAY) Q4 Earnings Expected to Decline Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business (“Wellspect”). Wellspect is a leading provider of bladder and bowel management care products with an over 40-year history. Through its comprehensive portfolio of products and accessories from trusted brands like LoFric® and Navina™, Wellspect has Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the “Board”), effective February 5, 2025. Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company’s digital X-Ray program. Mr. Scavi Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. Conference Call / Webcast Why Dentsply Sirona (XRAY) Is Among the Best 3D Printing and Additive Manufacturing Stocks to Buy? We recently compiled a list of the 11 Best 3D Printing and Additive Manufacturing Stocks To Buy. In this article, we are going to take a look at where DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stands against other best 3D printing and additive manufacturing stocks to buy. 3D printing is a process where a machine, known as a […] Dentsply Sirona to reposition Byte business within aligner portfolio DENTSPLY SIRONA (XRAY) announced that the company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the go-to-market business and economic model and expects to leverage collaborative direct-to-consumer demand generation with dentists using Byte core competencies, expand digital customer journey management across the aligner portfolio, and utilize Byte skillsets to further enhance customer service and marketing Return Trends At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Appealing What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common... Here’s What Dragged Dentsply Sirona (XRAY) in Q4 Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was up 1.97% in the fourth quarter compared to a 1.06% fall for the Russell 2000 Value Index. The fund outperformed the benchmark over the past 1, 3, […] Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio Company to Present at J.P. Morgan Healthcare ConferenceCHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the go-to-market business and economic model and expects to leverage collaborative direct-to-consumer (“DTC”) demand generation with dentists using Byte Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference CHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 15, 2025, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at DENTSPLY SIRONA (NASDAQ:XRAY) investors are sitting on a loss of 65% if they invested three years ago The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term... Dentsply Sirona Declares Quarterly Cash Dividend CHARLOTTE, N.C., Dec. 13, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on January 10, 2025, to holders of record as of December 27, 2024. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with ov What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players? On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now XRAY continues to gain traction from a robust product portfolio. However, the suspension of Byte's business and macroeconomic factors, such as weakened global demand, persist. Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$19.46? DENTSPLY SIRONA Inc. ( NASDAQ:XRAY ), is not the largest company out there, but it saw a decent share price growth of... Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference CHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 7th Annual Evercore ISI HealthCONx Conference. Management is scheduled to participate in a fireside chat discussion on December 5, 2024, at 8:20 am ET. Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona we Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer CHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Herman V. Cueto, a seasoned healthcare executive, has been appointed Interim Chief Financial Officer, effective immediately. He brings over two decades of experience leading and working in finance organizations across the healthcare industry. Mr. Cueto will oversee the finance organization while Dentsply Sirona completes its ongoing search for the Compa Dentsply (XRAY) International Revenue Performance Explored Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. DENTSPLY SIRONA Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags DENTSPLY SIRONA ( NASDAQ:XRAY ) Third Quarter 2024 Results Key Financial Results Revenue: US$951.0m (flat on 3Q 2023... Dentsply Sirona Inc (XRAY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges Despite revenue growth and strategic launches, Dentsply Sirona Inc (XRAY) faces macroeconomic pressures and regulatory hurdles impacting its outlook. Performance Overview Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return DY2.HM S&P 500 YTD +0.50% +2.24% 1-Year -39.59% +20.70% 3-Year -60.45% +38.27%